Literature DB >> 25367596

Long-Term Impact of Different Immunosuppressive Drugs on QT and PR Intervals in Renal Transplant Patients.

Baris Ikitimur1, Kahraman Cosansu2, Bilgehan Karadag1, Huseyin Altug Cakmak3, Burcak Kilickiran Avci1, Emre Erturk1, Nurhan Seyahi4, Zeki Ongen1.   

Abstract

BACKGROUND: Sudden cardiac deaths due to arrhythmias are thought to be an important cause of mortality in patients with renal transplants. Exposure to immunosuppressive drugs may lead to QT or PR interval abnormalities which may consequently cause arrhythmias. Our study investigated the long term impact of four different immunosuppressive drugs on PR and corrected QT intervals (QTc) in renal transplant patients
METHODS: The study population consisted of 98 kidney transplant recipients. Study patients were receiving immunosuppressive management with tacrolimus, cyclosporine A, everolimus or azathioprine according to the local protocols. QTc and PR intervals obtained from the most recent post-transplant electrocardiograms were compared with the pre-transplant intervals dated before the transplantation procedure.
RESULTS: Post-transplant QTc intervals had prolonged significantly in comparison to the pre-transplant QTc intervals in all groups. However, there were no significant differences between the immunosuppressive agents with regard to post-transplant QTc interval prolongation (p > 0.05). There were no significant differences between the groups with regard to the pre and post-transplant PR interval changes (p > 0.05).
CONCLUSIONS: QT interval prolongation, a marker of risk for arrhythmias and sudden death, is highly prevalent among kidney transplant patients receiving different classes of immunosuppressive drugs.
© 2014 Wiley Periodicals, Inc.

Entities:  

Keywords:  basic; clinical; pharmacokinetics/dynamics; pharmacology; ventricular tachycardia/fibrillation

Mesh:

Substances:

Year:  2014        PMID: 25367596      PMCID: PMC6931788          DOI: 10.1111/anec.12225

Source DB:  PubMed          Journal:  Ann Noninvasive Electrocardiol        ISSN: 1082-720X            Impact factor:   1.468


  36 in total

1.  Blinded validation of the isolated arterially perfused rabbit ventricular wedge in preclinical assessment of drug-induced proarrhythmias.

Authors:  Tengxian Liu; Barry S Brown; Ying Wu; Charles Antzelevitch; Peter R Kowey; Gan-Xin Yan
Journal:  Heart Rhythm       Date:  2006-04-22       Impact factor: 6.343

2.  QT interval prolongation in the patients receiving maintenance hemodialysis.

Authors:  R Suzuki; K Tsumura; T Inoue; H Kishimoto; H Morii
Journal:  Clin Nephrol       Date:  1998-04       Impact factor: 0.975

3.  Effect of hemodialysis on the dispersion of the QTc interval.

Authors:  A Cupisti; F Galetta; E Morelli; G Tintori; G Sibilia; M Meola; G Barsotti
Journal:  Nephron       Date:  1998       Impact factor: 2.847

4.  Ten-year graft survival of deceased-donor kidney transplantation: a single-center experience.

Authors:  Amir Almasi Hashiani; Abdolreza Rajaeefard; Jafar Hasanzadeh; Farzad Kakaei; Afshin Ghalehgolab Behbahan; Saman Nikeghbalian; Heshmatollah Salahi; Ali Bahador; Mehdi Salehipour; Seyed Ali Malek-Hosseini
Journal:  Ren Fail       Date:  2010-05       Impact factor: 2.606

5.  QT intervals in patients receiving a renal transplant.

Authors:  Ali Monfared; Zahra Atrkar Roshan; Arsalan Salari; Farshad Asadi; Mohammadkazem Lebadi; Masoud Khosravi; Sepiedeh Besharati
Journal:  Exp Clin Transplant       Date:  2012-04       Impact factor: 0.945

Review 6.  Assessing the relative risk of cardiovascular disease among renal transplant patients receiving tacrolimus or cyclosporine.

Authors:  Alan G Jardine
Journal:  Transpl Int       Date:  2005-04       Impact factor: 3.782

7.  Frequency and prognostic significance of QT prolongation in chronic renal failure patients.

Authors:  M Voiculescu; Camelia Ionescu; G Ismail
Journal:  Rom J Intern Med       Date:  2006

8.  QRS duration and mortality in patients with congestive heart failure.

Authors:  Stephen Iuliano; Susan G Fisher; Pamela E Karasik; Ross D Fletcher; Steven N Singh
Journal:  Am Heart J       Date:  2002-06       Impact factor: 4.749

9.  QT dispersion in renal transplant recipients.

Authors:  Mehmet Koc; Ahmet Toprak; I Cetin Ozener; Azra Bihorac; Hakan Tezcan; Ali Serdar Fak; Emel Akoglu
Journal:  Nephron       Date:  2002-06       Impact factor: 2.847

Review 10.  Cardiovascular disease in transplant recipients: current and future treatment strategies.

Authors:  John S Gill
Journal:  Clin J Am Soc Nephrol       Date:  2008-03       Impact factor: 8.237

View more
  7 in total

Review 1.  Clinical aspects of tacrolimus use in paediatric renal transplant recipients.

Authors:  Agnieszka Prytuła; Teun van Gelder
Journal:  Pediatr Nephrol       Date:  2018-02-26       Impact factor: 3.714

2.  Follow-Up (Measurement) of Corrected QT Interval in Adult Patients before and after Lung Transplantation.

Authors:  Dirk Bandorski; Reinhard Hoeltgen; Nicole Becker; Winfried Padberg; Harilaos Bogossian; Christoph Wiedenroth; Matthias Arlt; Christian Hamm; Werner Seeger; Hossein Ardeschir Ghofrani; Matthias Hecker; Henning Gall; Konstantin Mayer
Journal:  Biomed Res Int       Date:  2017-11-06       Impact factor: 3.411

Review 3.  Pharmacologic Treatment of Transplant Recipients Infected With SARS-CoV-2: Considerations Regarding Therapeutic Drug Monitoring and Drug-Drug Interactions.

Authors:  Laure Elens; Loralie J Langman; Dennis A Hesselink; Stein Bergan; Dirk Jan A R Moes; Mariadelfina Molinaro; Raman Venkataramanan; Florian Lemaitre
Journal:  Ther Drug Monit       Date:  2020-06       Impact factor: 3.681

Review 4.  Acquired long QT syndrome in chronic kidney disease patients.

Authors:  Peng Liu; Lu Wang; Dan Han; Chaofeng Sun; Xiaolin Xue; Guoliang Li
Journal:  Ren Fail       Date:  2020-11       Impact factor: 2.606

Review 5.  Potential drug-drug interactions associated with drugs currently proposed for COVID-19 treatment in patients receiving other treatments.

Authors:  Florian Lemaitre; Caroline Solas; Matthieu Grégoire; Laurence Lagarce; Laure Elens; Elisabeth Polard; Béatrice Saint-Salvi; Agnès Sommet; Michel Tod; Chantal Barin-Le Guellec
Journal:  Fundam Clin Pharmacol       Date:  2020-07-24       Impact factor: 2.747

6.  Ticagrelor-Induced Prolongation of the QTc Interval.

Authors:  Avik Ray; Ahmad Najmi; Gaurav Khandelwal; Balakrishnan Sadasivam
Journal:  Case Rep Cardiol       Date:  2019-11-07

Review 7.  Antivirals for COVID-19 in Solid Organ Transplant Recipients.

Authors:  Justin C Laracy; Elizabeth C Verna; Marcus R Pereira
Journal:  Curr Transplant Rep       Date:  2020-10-21
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.